Free Newsletter
| Get the pharma industry's daily monitor, with a special focus on pharmaceutical company news and the market development of FDA approved products. Sign up for free today! |
SPOTLIGHT: Quality control at Chinese heparin supplier
Curious how APP Pharmaceuticals' heparin supplier in China handles safety and quality control? Check out The Wall Street Journal's behind-the-scenes look at Shenzhen Hepalink Pharmaceutical. APP, remember, is supplying the lion's share of heparin in the U.S. in the wake of Baxter's big recall and production stoppage. Report
Be the first to comment
Comments
Post new comment
Paid Research Reports
- RNA therapy: the next big thing after monoclonal antibodies?
- Biotech M&A Strategies: Deal assessments, trends and future prospects
- The Dermatology Market Outlook to 2013: Competitive landscape, pipeline analysis and growth opportunities
- Pipeline Insight: Cancer Overview - Breast, Gynecological, Genitourinary - Diverse drugs approaching the market for many tumor t
- Sales Force Effectiveness
- Forecast Model: Antidyslipidemics - Genericization and negative trial data drive market shrinkage
